In September of 2017, "Hepatology" officially published the research results of the team of professor Urban S. in the field of hepatitis B virus infection, confirming that hNTCP is a limiting factor in pig and monkey's hepatocytes. Meaning that going through the hNTCP overexpression, it supports the efficient infection of hepatitis B virus to pig and monkey hepatocyte, including the formation of cccDNA. The greatest academic significance of the result is that the limitation of primary hepatocyte models of hepatitis B virus infection and the limitation of animal models with a complete immune system are expected to be able to solved. Thereby promoting the development of hepatitis B virus drugs and the optimization of treatment strategies (link: http://onlinelibrary.wiley.com/doi/10.1002/hep.29112/abstract).

Liver-Biotech has also developed an infection model based on hNTCP stably transferring pig primary hepatocytes and confirmed that it has good HBV susceptibility, our product has also confirmed that it has a very good performance on the cost. Welcome to order from Liver-Biotech.